Open access
83
Views
13
CrossRef citations to date
0
Altmetric
Original Research
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification
David B Price1 University of Aberdeen, Division of Applied Health Sciences, Aberdeen, UK
, Christine L Baker2 Pfizer Inc, Outcomes and Evidence, Global Health and Value, New York, USA
, Kelly H Zou3 Pfizer Inc, Statistical Center for Outcomes, Real-World and Aggregate Data, Global Innovative Pharma Business, New York, USA
, Victoria S Higgins4 Adelphi Real World, Macclesfield, UKCorrespondence[email protected]
, James T Bailey4 Adelphi Real World, Macclesfield, UK
& James S Pike4 Adelphi Real World, Macclesfield, UK
Pages 551-561
|
Published online: 28 May 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.